Merck, Bristol drugs show longer survival for deadly cancers

NEW YORK, May 18 (Reuters) - Two new drugs that help the immune system fight some of the deadliest cancers are helping patients live years longer than older treatments, according to clinical trial results that should further boost confidence in this approach to oncology.